While HIV is no longer the death sentence it once was, we are yet to defeat it entirely. However, a new study from Oxford University offers hope that HIV will eventually have nowhere to hide. Tom Calver spoke to Professor Lucy Dorrell (Jenner Investigator) about her work on clearing HIV from the body.
CONACyT will fund through its 2016 “Frontiers of Science” call a project submitted by Dr Héctor Vivanco Cid of Universidad Veracruzana in collaboration with Prof Reyes-Sandoval Group, The Jenner Institute, Nuffield Department of Medicine. The study will take place in in the sate of Veracruz, which has had the highest numbers of cases of dengue fever and dengue haemorrhagic fever in Mexico in recent years, and the highest number of hospitalisations due to this disease. It is expected that chikungunya and zika viruses will become endemic in this region as well.
Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell Receptors. Mol Ther. Article
The predicted persistence and kinetics of antibody decline 9years after pre-school booster vaccination in UK children. Vaccine. Article
Clinical trials are an essential part of vaccine development, and our volunteers play a critical role in our studies.
If you would like to find out more about paid clinical trials, and what is involved in participating, please go to our Recruiting Trials page to see which trials are currently recruiting.
Prof Robert Sauerwein: Title TBC, 28/Sep/2016 12:00
Prof Gavin Screaton: Human antibody responses to dengue/Zika virus infections, 13/Oct/2016 13:30